FDA Approves Teva's Generic OxyContin
Teva said the approval applies to 10-, 20- and 40-milligram extended release tablets of the oxycodone hydrochloride drug. The company previously received approval from the U.S. Food and Drug Administration for an 80-milligram version of OxyContin and began shipping that product on March 30.
Teva received 6 months exclusivity for the 80-milligram version of OxyContin and launched the product "at-risk," meaning...
To view the full article, register now.